NR1D1 and adenocarcinoma: Together with the data described above, our results demonstrated that REV-ERBα function is reprogrammed in prostate cancer progression from activating tumorigenic kinase signaling and metabolic programs in adenocarcinoma to activating LP gene programs in NEPC.